Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 63 entries
Sorted by: Best Match Show Resources per page
Socioeconomic status and the 25× 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1· 7 million men and …

socioeconomic status & related terms (e.g., low income)

Stringhini S, Carmeli C, Jokela M, Avendaño M.
GSID: mG2ik1HEi7sJ
S Stringhini, C Carmeli, M Jokela, M Avendaño… - The Lancet, 2017 - Elsevier

… For example, low socioeconomic status might induce changes in one or more risk factors, … also reduce labour supply and earnings, thereby lowering socioeconomic status. Furthermore, …

Cite
Stringhini, S., Carmeli, C., Jokela, M., Avendaño, M., Muennig, P., Guida, F., ... & Tumino, R. (2017). Socioeconomic status and the 25× 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1· 7 million men and women. The Lancet, 389(10075), 1229-1237.
Stringhini, Silvia, et al. "Socioeconomic status and the 25× 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1· 7 million men and women." The Lancet 389.10075 (2017): 1229-1237.
Copy Download .nbib Format: MLA
Socioeconomic status and risk factors for non-communicable diseases in low-income and lower-middle-income countries

socioeconomic status & related terms (e.g., low income)

Stringhini S, Bovet P.
GSID: ojZTjSEucv8J
S Stringhini, P Bovet - The Lancet Global Health, 2017 - thelancet.com

… (eg, how to define socioeconomic status in these LLMICs and how to compare results between countries). Furthermore, the social patterning of risk factors might differ between countries …

Cite
Stringhini, S., & Bovet, P. (2017). Socioeconomic status and risk factors for non-communicable diseases in low-income and lower-middle-income countries. The Lancet Global Health, 5(3), e230-e231.
Stringhini, Silvia, and Pascal Bovet. "Socioeconomic status and risk factors for non-communicable diseases in low-income and lower-middle-income countries." The Lancet Global Health 5.3 (2017): e230-e231.
Copy Download .nbib Format: MLA
Acute respiratory distress syndrome associated with tumor lysis syndrome in a child with acute lymphoblastic leukemia.

Pediatric reports

Macaluso A, Genova S, Maringhini S, Coffaro G, Ziino O, D'Angelo P.
PMID: 25918625
Pediatr Rep. 2015 Mar 27;7(1):5760. doi: 10.4081/pr.2015.5760. eCollection 2015 Feb 24.

Tumor lysis syndrome is a serious and dangerous complication usually associated with antiblastic treatment in some malignancies characterized by high cell turn-over. Mild or severe electrolyte abnormalities including high serum levels of uric acid, potassium, phosphorus, creatinine, bun and...

Cite
Macaluso A, Genova S, Maringhini S, et al. Acute respiratory distress syndrome associated with tumor lysis syndrome in a child with acute lymphoblastic leukemia. Pediatr Rep. 2015;7(1):5760doi: 10.4081/pr.2015.5760.
Macaluso, A., Genova, S., Maringhini, S., Coffaro, G., Ziino, O., & D'Angelo, P. (2015). Acute respiratory distress syndrome associated with tumor lysis syndrome in a child with acute lymphoblastic leukemia. Pediatric reports, 7(1), 5760. https://doi.org/10.4081/pr.2015.5760
Macaluso, Alessandra, et al. "Acute respiratory distress syndrome associated with tumor lysis syndrome in a child with acute lymphoblastic leukemia." Pediatric reports vol. 7,1 (2015): 5760. doi: https://doi.org/10.4081/pr.2015.5760
Macaluso A, Genova S, Maringhini S, Coffaro G, Ziino O, D'Angelo P. Acute respiratory distress syndrome associated with tumor lysis syndrome in a child with acute lymphoblastic leukemia. Pediatr Rep. 2015 Mar 27;7(1):5760. doi: 10.4081/pr.2015.5760. eCollection 2015 Feb 24. PMID: 25918625; PMCID: PMC4387330.
Copy Download .nbib Format: NLM
The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization.

Environmental research

Vineis P, Stringhini S, Porta M.
PMID: 24593864
Environ Res. 2014 Aug;133:424-30. doi: 10.1016/j.envres.2014.02.002. Epub 2014 Mar 01.

BACKGROUND: Non-communicable diseases (NCDs) are increasing worldwide. We hypothesize that environmental factors (including social adversity, diet, lack of physical activity and pollution) can become "embedded" in the biology of humans. We also hypothesize that the "embedding" partly occurs because...

Cite
Vineis P, Stringhini S, Porta M. The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization. Environ Res. 2014;133:424-30doi: 10.1016/j.envres.2014.02.002.
Vineis, P., Stringhini, S., & Porta, M. (2014). The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization. Environmental research, 133424-30. https://doi.org/10.1016/j.envres.2014.02.002
Vineis, Paolo, et al. "The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization." Environmental research vol. 133 (2014): 424-30. doi: https://doi.org/10.1016/j.envres.2014.02.002
Vineis P, Stringhini S, Porta M. The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization. Environ Res. 2014 Aug;133:424-30. doi: 10.1016/j.envres.2014.02.002. Epub 2014 Mar 01. PMID: 24593864.
Copy Download .nbib Format: NLM
Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests.

Journal of clinical medicine

Andrey DO, Cohen P, Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Guessous I, Stringhini S, Roux-Lombard P, Fontao L, Agoritsas T, Stirnemann J, Reny JL, Siegrist CA, Eckerle I, Kaiser L, Vuilleumier N.
PMID: 32722191
J Clin Med. 2020 Jul 24;9(8). doi: 10.3390/jcm9082369.

BACKGROUND: Comparative data of SARS-CoV-2 IgM/IgG serology rapid diagnostic tests (RDTs) is scarce. We thus performed a head-to-head comparison of three RDTs.METHODS: In this unmatched case-control study, blood samples from 41 RT-PCR-confirmed COVID-19 cases and 50 negative controls were...

Cite
Andrey DO, Cohen P, Meyer B, et al. Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. J Clin Med. 2020;9(8)doi: 10.3390/jcm9082369.
Andrey, D. O., Cohen, P., Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm-Vernez, I., Guessous, I., Stringhini, S., Roux-Lombard, P., Fontao, L., Agoritsas, T., Stirnemann, J., Reny, J. L., Siegrist, C. A., Eckerle, I., Kaiser, L., & Vuilleumier, N. (2020). Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. Journal of clinical medicine, 9(8), . https://doi.org/10.3390/jcm9082369
Andrey, Diego O, et al. "Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests." Journal of clinical medicine vol. 9,8 (2020). doi: https://doi.org/10.3390/jcm9082369
Andrey DO, Cohen P, Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Guessous I, Stringhini S, Roux-Lombard P, Fontao L, Agoritsas T, Stirnemann J, Reny JL, Siegrist CA, Eckerle I, Kaiser L, Vuilleumier N. Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. J Clin Med. 2020 Jul 24;9(8). doi: 10.3390/jcm9082369. PMID: 32722191; PMCID: PMC7463984.
Copy Download .nbib Format: NLM
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS.
PMID: 34245905
Clin Microbiol Infect. 2021 Nov;27(11):1695.e7-1695.e12. doi: 10.1016/j.cmi.2021.06.040. Epub 2021 Jul 07.

OBJECTIVES: Serological studies have been critical in tracking the evolution of the COVID-19 pandemic. Data on anti-SARS-CoV-2 antibodies persistence remain sparse, especially from infected individuals with few to no symptoms. The objective of the study was to quantify the...

Cite
Perez-Saez J, Zaballa ME, Yerly S, et al. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021;27(11):1695.e7-1695.e12doi: 10.1016/j.cmi.2021.06.040.
Perez-Saez, J., Zaballa, M. E., Yerly, S., Andrey, D. O., Meyer, B., Eckerle, I., Balavoine, J. F., Chappuis, F., Pittet, D., Trono, D., Kherad, O., Vuilleumier, N., Kaiser, L., Guessous, I., Stringhini, S., Azman, A. S. (2021). Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(11), 1695.e7-1695.e12. https://doi.org/10.1016/j.cmi.2021.06.040
Perez-Saez, Javier, et al. "Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 27,11 (2021): 1695.e7-1695.e12. doi: https://doi.org/10.1016/j.cmi.2021.06.040
Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS. Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov;27(11):1695.e7-1695.e12. doi: 10.1016/j.cmi.2021.06.040. Epub 2021 Jul 07. PMID: 34245905; PMCID: PMC8261139.
Copy Download .nbib Format: NLM
Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies.

Mayo Clinic proceedings

Petrovic D, Pruijm M, Ponte B, Dhayat NA, Ackermann D, Ehret G, Ansermot N, Vogt B, Martin PY, Stringhini S, Estoppey-Younès S, Thijs L, Zhang Z, Melgarejo JD, Eap CB, Staessen JA, Bochud M, Guessous I.
PMID: 34579945
Mayo Clin Proc. 2021 Dec;96(12):3071-3085. doi: 10.1016/j.mayocp.2021.05.030. Epub 2021 Sep 25.

OBJECTIVE: To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries.METHODS: Families were randomly selected from the general population of northern Belgium (FLEMENGHO), from August 12, 1985, until November...

Cite
Petrovic D, Pruijm M, Ponte B, et al. Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies. Mayo Clin Proc. 2021;96(12):3071-3085doi: 10.1016/j.mayocp.2021.05.030.
Petrovic, D., Pruijm, M., Ponte, B., Dhayat, N. A., Ackermann, D., Ehret, G., Ansermot, N., Vogt, B., Martin, P. Y., Stringhini, S., Estoppey-Younès, S., Thijs, L., Zhang, Z., Melgarejo, J. D., Eap, C. B., Staessen, J. A., Bochud, M., & Guessous, I. (2021). Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies. Mayo Clinic proceedings, 96(12), 3071-3085. https://doi.org/10.1016/j.mayocp.2021.05.030
Petrovic, Dusan, et al. "Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies." Mayo Clinic proceedings vol. 96,12 (2021): 3071-3085. doi: https://doi.org/10.1016/j.mayocp.2021.05.030
Petrovic D, Pruijm M, Ponte B, Dhayat NA, Ackermann D, Ehret G, Ansermot N, Vogt B, Martin PY, Stringhini S, Estoppey-Younès S, Thijs L, Zhang Z, Melgarejo JD, Eap CB, Staessen JA, Bochud M, Guessous I. Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies. Mayo Clin Proc. 2021 Dec;96(12):3071-3085. doi: 10.1016/j.mayocp.2021.05.030. Epub 2021 Sep 25. PMID: 34579945.
Copy Download .nbib Format: NLM
Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus.

Nature communications

Tin A, Schlosser P, Matias-Garcia PR, Thio CHL, Joehanes R, Liu H, Yu Z, Weihs A, Hoppmann A, Grundner-Culemann F, Min JL, Kuhns VLH, Adeyemo AA, Agyemang C, Ärnlöv J, Aziz NA, Baccarelli A, Bochud M, Brenner H, Bressler J, Breteler MMB, Carmeli C, Chaker L, Coresh J, Corre T, Correa A, Cox SR, Delgado GE, Eckardt KU, Ekici AB, Endlich K, Floyd JS, Fraszczyk E, Gao X, Gào X, Gelber AC, Ghanbari M, Ghasemi S, Gieger C, Greenland P, Grove ML, Harris SE, Hemani G, Henneman P, Herder C, Horvath S, Hou L, Hurme MA, Hwang SJ, Kardia SLR, Kasela S, Kleber ME, Koenig W, Kooner JS, Kronenberg F, Kühnel B, Ladd-Acosta C, Lehtimäki T, Lind L, Liu D, Lloyd-Jones DM, Lorkowski S, Lu AT, Marioni RE, März W, McCartney DL, Meeks KAC, Milani L, Mishra PP, Nauck M, Nowak C, Peters A, Prokisch H, Psaty BM, Raitakari OT, Ratliff SM, Reiner AP, Schöttker B, Schwartz J, Sedaghat S, Smith JA, Sotoodehnia N, Stocker HR, Stringhini S, Sundström J, Swenson BR, van Meurs JBJ, van Vliet-Ostaptchouk JV, Venema A, Völker U, Winkelmann J, Wolffenbuttel BHR, Zhao W, Zheng Y, Loh M, Snieder H, Waldenberger M, Levy D, Akilesh S, Woodward OM, Susztak K, Teumer A, Köttgen A.
PMID: 34887389
Nat Commun. 2021 Dec 09;12(1):7173. doi: 10.1038/s41467-021-27198-4.

Elevated serum urate levels, a complex trait and major risk factor for incident gout, are correlated with cardiometabolic traits via incompletely understood mechanisms. DNA methylation in whole blood captures genetic and environmental influences and is assessed in transethnic meta-analysis...

Cite
Tin A, Schlosser P, Matias-Garcia PR, et al. Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus. Nat Commun. 2021;12(1):7173doi: 10.1038/s41467-021-27198-4.
Tin, A., Schlosser, P., Matias-Garcia, P. R., Thio, C. H. L., Joehanes, R., Liu, H., Yu, Z., Weihs, A., Hoppmann, A., Grundner-Culemann, F., Min, J. L., Kuhns, V. L. H., Adeyemo, A. A., Agyemang, C., Ärnlöv, J., Aziz, N. A., Baccarelli, A., Bochud, M., Brenner, H., Bressler, J., Breteler, M. M. B., Carmeli, C., Chaker, L., Coresh, J., Corre, T., Correa, A., Cox, S. R., Delgado, G. E., Eckardt, K. U., Ekici, A. B., Endlich, K., Floyd, J. S., Fraszczyk, E., Gao, X., Gào, X., Gelber, A. C., Ghanbari, M., Ghasemi, S., Gieger, C., Greenland, P., Grove, M. L., Harris, S. E., Hemani, G., Henneman, P., Herder, C., Horvath, S., Hou, L., Hurme, M. A., Hwang, S. J., Kardia, S. L. R., Kasela, S., Kleber, M. E., Koenig, W., Kooner, J. S., Kronenberg, F., Kühnel, B., Ladd-Acosta, C., Lehtimäki, T., Lind, L., Liu, D., Lloyd-Jones, D. M., Lorkowski, S., Lu, A. T., Marioni, R. E., März, W., McCartney, D. L., Meeks, K. A. C., Milani, L., Mishra, P. P., Nauck, M., Nowak, C., Peters, A., Prokisch, H., Psaty, B. M., Raitakari, O. T., Ratliff, S. M., Reiner, A. P., Schöttker, B., Schwartz, J., Sedaghat, S., Smith, J. A., Sotoodehnia, N., Stocker, H. R., Stringhini, S., Sundström, J., Swenson, B. R., van Meurs, J. B. J., van Vliet-Ostaptchouk, J. V., Venema, A., Völker, U., Winkelmann, J., Wolffenbuttel, B. H. R., Zhao, W., Zheng, Y., Loh, M., Snieder, H., Waldenberger, M., Levy, D., Akilesh, S., Woodward, O. M., Susztak, K., Teumer, A., & Köttgen, A. (2021). Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus. Nature communications, 12(1), 7173. https://doi.org/10.1038/s41467-021-27198-4
Tin, Adrienne, et al. "Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus." Nature communications vol. 12,1 (2021): 7173. doi: https://doi.org/10.1038/s41467-021-27198-4
Tin A, Schlosser P, Matias-Garcia PR, Thio CHL, Joehanes R, Liu H, Yu Z, Weihs A, Hoppmann A, Grundner-Culemann F, Min JL, Kuhns VLH, Adeyemo AA, Agyemang C, Ärnlöv J, Aziz NA, Baccarelli A, Bochud M, Brenner H, Bressler J, Breteler MMB, Carmeli C, Chaker L, Coresh J, Corre T, Correa A, Cox SR, Delgado GE, Eckardt KU, Ekici AB, Endlich K, Floyd JS, Fraszczyk E, Gao X, Gào X, Gelber AC, Ghanbari M, Ghasemi S, Gieger C, Greenland P, Grove ML, Harris SE, Hemani G, Henneman P, Herder C, Horvath S, Hou L, Hurme MA, Hwang SJ, Kardia SLR, Kasela S, Kleber ME, Koenig W, Kooner JS, Kronenberg F, Kühnel B, Ladd-Acosta C, Lehtimäki T, Lind L, Liu D, Lloyd-Jones DM, Lorkowski S, Lu AT, Marioni RE, März W, McCartney DL, Meeks KAC, Milani L, Mishra PP, Nauck M, Nowak C, Peters A, Prokisch H, Psaty BM, Raitakari OT, Ratliff SM, Reiner AP, Schöttker B, Schwartz J, Sedaghat S, Smith JA, Sotoodehnia N, Stocker HR, Stringhini S, Sundström J, Swenson BR, van Meurs JBJ, van Vliet-Ostaptchouk JV, Venema A, Völker U, Winkelmann J, Wolffenbuttel BHR, Zhao W, Zheng Y, Loh M, Snieder H, Waldenberger M, Levy D, Akilesh S, Woodward OM, Susztak K, Teumer A, Köttgen A. Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus. Nat Commun. 2021 Dec 09;12(1):7173. doi: 10.1038/s41467-021-27198-4. PMID: 34887389.
Copy Download .nbib Format: NLM
Digital COVID Credentials: An Implementation Process.

Frontiers in digital health

Nehme M, Kaiser L, Gillet P, Thevoz P, Stringhini S, Guessous I.
PMID: 34713082
Front Digit Health. 2021 Jun 25;3:594124. doi: 10.3389/fdgth.2021.594124. eCollection 2021.

No abstract available.

Cite
Nehme M, Kaiser L, Gillet P, et al. Digital COVID Credentials: An Implementation Process. Front Digit Health. 2021;3:594124doi: 10.3389/fdgth.2021.594124.
Nehme, M., Kaiser, L., Gillet, P., Thevoz, P., Stringhini, S., & Guessous, I. (2021). Digital COVID Credentials: An Implementation Process. Frontiers in digital health, 3594124. https://doi.org/10.3389/fdgth.2021.594124
Nehme, Mayssam, et al. "Digital COVID Credentials: An Implementation Process." Frontiers in digital health vol. 3 (2021): 594124. doi: https://doi.org/10.3389/fdgth.2021.594124
Nehme M, Kaiser L, Gillet P, Thevoz P, Stringhini S, Guessous I. Digital COVID Credentials: An Implementation Process. Front Digit Health. 2021 Jun 25;3:594124. doi: 10.3389/fdgth.2021.594124. eCollection 2021. PMID: 34713082; PMCID: PMC8521819.
Copy Download .nbib Format: NLM
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study.

Breast cancer research and treatment

Klinger M, Losurdo A, Lisa AVE, Morenghi E, Vinci V, Corsi F, Albasini S, Leonardi MC, Jereczek-Fossa BA, Veronesi P, Rietjens M, Fabiocchi L, Santicchia S, Klinger F, Loreti A, Fortunato L, Bocchiotti MA, Nicolò FA, Stringhini P, Parodi PC, Rampino E, Guarneri V, Pagura G, Venezia ED, Meneghini G, Kraljic T, Persichetti P, Barone M, Vaia N, Zerini I, Grimaldi L, Riccio M, Aquinati A, Bassetto F, Vindigni V, Ciuffreda L, Tinterri C, Santoro A.
PMID: 34755240
Breast Cancer Res Treat. 2022 Jan;191(2):355-363. doi: 10.1007/s10549-021-06444-9. Epub 2021 Nov 09.

BACKGROUND: Autologous fat grafting (AFG), defined as the re-implant to the breast of fat tissue from different body areas, has been firstly applied to esthetic plastic surgery and then has moved to reconstructive surgery, mainly used for scar correction...

Cite
Klinger M, Losurdo A, Lisa AVE, et al. Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study. Breast Cancer Res Treat. 2021;191(2):355-363doi: 10.1007/s10549-021-06444-9.
Klinger, M., Losurdo, A., Lisa, A. V. E., Morenghi, E., Vinci, V., Corsi, F., Albasini, S., Leonardi, M. C., Jereczek-Fossa, B. A., Veronesi, P., Rietjens, M., Fabiocchi, L., Santicchia, S., Klinger, F., Loreti, A., Fortunato, L., Bocchiotti, M. A., Nicolò, F. A., Stringhini, P., Parodi, P. C., Rampino, E., Guarneri, V., Pagura, G., Venezia, E. D., Meneghini, G., Kraljic, T., Persichetti, P., Barone, M., Vaia, N., Zerini, I., Grimaldi, L., Riccio, M., Aquinati, A., Bassetto, F., Vindigni, V., Ciuffreda, L., Tinterri, C., & Santoro, A. (2022). Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study. Breast cancer research and treatment, 191(2), 355-363. https://doi.org/10.1007/s10549-021-06444-9
Klinger, Marco, et al. "Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study." Breast cancer research and treatment vol. 191,2 (2022): 355-363. doi: https://doi.org/10.1007/s10549-021-06444-9
Klinger M, Losurdo A, Lisa AVE, Morenghi E, Vinci V, Corsi F, Albasini S, Leonardi MC, Jereczek-Fossa BA, Veronesi P, Rietjens M, Fabiocchi L, Santicchia S, Klinger F, Loreti A, Fortunato L, Bocchiotti MA, Nicolò FA, Stringhini P, Parodi PC, Rampino E, Guarneri V, Pagura G, Venezia ED, Meneghini G, Kraljic T, Persichetti P, Barone M, Vaia N, Zerini I, Grimaldi L, Riccio M, Aquinati A, Bassetto F, Vindigni V, Ciuffreda L, Tinterri C, Santoro A. Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study. Breast Cancer Res Treat. 2022 Jan;191(2):355-363. doi: 10.1007/s10549-021-06444-9. Epub 2021 Nov 09. PMID: 34755240.
Copy Download .nbib Format: NLM
COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study.

Swiss medical weekly

Wisniak A, Baysson H, Pullen N, Nehme M, Pennacchio F, Zaballa ME, Guessous I, Stringhini S.
PMID: 34908389
Swiss Med Wkly. 2021 Dec 14;151:w30080. doi: 10.4414/smw.2021.w30080. eCollection 2021 Dec 06.

OBJECTIVE: This study aimed to assess acceptance of COVID-19 vaccination as well as its sociodemographic and clinical determinants, 3 months after the launch of the vaccination programme in Geneva, Switzerland.METHODS: In March 2021, an online questionnaire was proposed to...

Cite
Wisniak A, Baysson H, Pullen N, et al. COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study. Swiss Med Wkly. 2021;151:w30080doi: 10.4414/smw.2021.w30080.
Wisniak, A., Baysson, H., Pullen, N., Nehme, M., Pennacchio, F., Zaballa, M. E., Guessous, I., Stringhini, S. (2021). COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study. Swiss medical weekly, 151w30080. https://doi.org/10.4414/smw.2021.w30080
Wisniak, Ania, et al. "COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study." Swiss medical weekly vol. 151 (2021): w30080. doi: https://doi.org/10.4414/smw.2021.w30080
Wisniak A, Baysson H, Pullen N, Nehme M, Pennacchio F, Zaballa ME, Guessous I, Stringhini S. COVID-19 vaccination acceptance in the canton of Geneva: a cross-sectional population-based study. Swiss Med Wkly. 2021 Dec 14;151:w30080. doi: 10.4414/smw.2021.w30080. eCollection 2021 Dec 06. PMID: 34908389.
Copy Download .nbib Format: NLM
Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors.

Oncotarget

Mortensen MR, Mock J, Bertolini M, Stringhini M, Catalano M, Neri D.
PMID: 33216834
Oncotarget. 2020 Nov 03;11(44):3972-3983. doi: 10.18632/oncotarget.27772. eCollection 2020 Nov 03.

There is a growing interest in the antibody-based delivery of cytokines to the tumor environment as a means to boost the anti-cancer activity of tumor-resident T cells and NK cells. Here, we describe the expression and characterization of fusion...

Cite
Mortensen MR, Mock J, Bertolini M, et al. Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors. Oncotarget. 2020;11(44):3972-3983doi: 10.18632/oncotarget.27772.
Mortensen, M. R., Mock, J., Bertolini, M., Stringhini, M., Catalano, M., & Neri, D. (2020). Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors. Oncotarget, 11(44), 3972-3983. https://doi.org/10.18632/oncotarget.27772
Mortensen, Michael R, et al. "Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors." Oncotarget vol. 11,44 (2020): 3972-3983. doi: https://doi.org/10.18632/oncotarget.27772
Mortensen MR, Mock J, Bertolini M, Stringhini M, Catalano M, Neri D. Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors. Oncotarget. 2020 Nov 03;11(44):3972-3983. doi: 10.18632/oncotarget.27772. eCollection 2020 Nov 03. PMID: 33216834; PMCID: PMC7646832.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 63 entries